Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q1 2022 vs. Q4 2021
How the institutions holding Biofrontera Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 15 | 12 | −3 |
| Shares | 701.4K | 798.5K | +97.1K (+13.8%) |
| Value | $5.29M | $2.66M | −$2.63M (−49.7%) |
New holders (5)
Institutions that held Biofrontera Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 89,300 | $298.0K | 0.00% |
| Citadel Advisors LLC | 50,506 | $168.0K | 0.00% |
| State Street Corp | 14,700 | $49.0K | 0.00% |
| XTX Topco Ltd | 14,336 | $48.0K | 0.02% |
| Citigroup Inc | 2,000 | $7.00K | 0.00% |
Sold out (8)
Institutions that held Biofrontera Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Verition Fund Management LLC | 55,898 | $420.0K |
| Susquehanna International Group, LLP | 51,010 | $384.0K |
| Qube Research & Technologies Ltd | 13,700 | $103.0K |
| Federation des caisses Desjardins du Quebec | 900 | $6.77K |
| Advisor Group Holdings, Inc. | 400 | $3.00K |
| Tower Research Capital LLC (TRC) | 158 | $1.00K |
| Morgan Stanley | 6 | $0 |
| Royal Bank of Canada | 25 | $0 |